Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - CALYPTE BIOMEDICAL CORP | calypte_10k-123110.htm |
| EX-31.1 - EXHIBIT 31.1 - CALYPTE BIOMEDICAL CORP | ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - CALYPTE BIOMEDICAL CORP | ex23-1.htm |
| EX-10.200 - EXHIBIT 10.200 - CALYPTE BIOMEDICAL CORP | ex10-200.htm |
| EX-10.146 - EXHIBIT 10.146 - CALYPTE BIOMEDICAL CORP | ex10-146.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K of Calypte Biomedical Corporation (the “Company”) for the year ended December 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.
May 25, 2011
/s/ Adel Karas
Adel Karas
President, Chief Executive Officer and
Chief Financial Officer (Principal Executive
and Financial Officer)